Gavin is joined by Dr. Seth Berkley, former CEO of Gavi, the Vaccine Alliance, to discuss his new book, Fair Doses. Dr. Berkley reflects on the global impact of vaccines, the ongoing challenges to vaccine equity, and the lessons learned from leading initiatives such as COVAX during the COVID-19 pandemic. We also discuss the economics of vaccine distribution, the threat of misinformation, the promise of scientific innovation, and the future of global health preparedness, and a vision for str...
All content for The Lancet Voice is the property of The Lancet Group and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Gavin is joined by Dr. Seth Berkley, former CEO of Gavi, the Vaccine Alliance, to discuss his new book, Fair Doses. Dr. Berkley reflects on the global impact of vaccines, the ongoing challenges to vaccine equity, and the lessons learned from leading initiatives such as COVAX during the COVID-19 pandemic. We also discuss the economics of vaccine distribution, the threat of misinformation, the promise of scientific innovation, and the future of global health preparedness, and a vision for str...
Gavin, Richard, and Jessamy return to the studio to discuss some publications that caught their eye this month, and in doing so set themselves the lofty goal of examining how meaning, purpose, optimism, and social context shape our understanding of health beyond traditional clinical measures. We also ponder the future of research and higher education in the face of funding challenges in both the US and the UK. Articles mentioned in this episode: The Global Flourishing Study: https://www.natur...
The Lancet Voice
Gavin is joined by Dr. Seth Berkley, former CEO of Gavi, the Vaccine Alliance, to discuss his new book, Fair Doses. Dr. Berkley reflects on the global impact of vaccines, the ongoing challenges to vaccine equity, and the lessons learned from leading initiatives such as COVAX during the COVID-19 pandemic. We also discuss the economics of vaccine distribution, the threat of misinformation, the promise of scientific innovation, and the future of global health preparedness, and a vision for str...
